Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.6000
+0.0170 (2.92%)
At close: Jun 26, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $1.06 million as of June 26, 2026. Its market cap has decreased by -95.64% in one year.
Market Cap
1.06M
Enterprise Value
15.43M
Revenue
398.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.60
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 1.06M, a decrease of -99.54%. That is a compound annual growth rate of -58.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.06M | -80.52% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hepion Pharmaceuticals | 1.57M |
| ZyVersa Therapeutics | 1.51M |
| International Stem Cell | 1.48M |
| inTerra Resources | 1.47M |
| Abpro Holdings | 1.33M |
| Neon Bloom | 1.27M |
| Evofem Biosciences | 1.09M |
| Clearside Biomedical | 1.02M |